BOULDER, Colo., May 5 /PRNewswire-FirstCall/ -- Tapestry Pharmaceuticals, Inc. today announced that Leonard P. Shaykin, Chairman and Chief Executive Officer of Tapestry, will present an overview of the Company’s progress and strategy at the Rodman & Renshaw Techvest Global Healthcare Conference on Thursday, May 13, 2004 at 10:30 AM Eastern Daylight Time (3:30 PM Greenwich Mean Time) at Claridge’s Hotel in London, United Kingdom.
Rodman & Renshaw will provide a live audio webcast of the presentation, which can be accessed through Tapestry’s website at http://www.tapestrypharma.com/. A replay of the webcast will be available for 90 days.
About Tapestry Pharmaceuticals
Tapestry Pharmaceuticals, Inc. is a company focused on the development of proprietary therapies for the treatment of cancer and hereditary disease.
Statements in this press release regarding Tapestry Pharmaceuticals, Inc.'s business which are not historical facts are “forward-looking statements” that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see “Special Note Regarding Forward Looking Statements” in the Company’s Annual Report or Form 10-K for the most recently completed fiscal year.
For further information, please contact L. Robert Cohen, Vice President, Investor Relations of Tapestry Pharmaceuticals, Inc., 212 218 8715.
Tapestry Pharmaceuticals, Inc.
CONTACT: L. Robert Cohen, Vice President, Investor Relations of TapestryPharmaceuticals, Inc., +1-212-218-8715; or Investors - Lilian Stern of SternInvestor Relations, Inc., +1-212-362-1200, or Media - Peter Steinerman,+1-516-374-3031, both for Tapestry Pharmaceuticals, Inc.
Web site: http://www.tapestrypharma.com/
